Novus Therapeutics Inc. (NVUS) Tumbled -6.23% or -0.25 To Price $3.83 On Tuesday


Novus Therapeutics Inc. (NVUS) tumbled -6.23% or -0.25 to $3.83. It is around 15398 shares traded, which is 6.42% compare to the average total volume 239716. The market cap of NVUS is $36.05 million. The year to date change is -3.71%. The 52 week price range is from $3.12 to $8.61. Price of NVUS have changed -8.31% during last week. It have changed -9.93% over last month, -45.60% over last 3 months, -25.41% over last 6 months and -17.07% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVUS is 5.00. It is 30.55% above current price. The 200-day Moving Averages for NVUS is 5.10. It is 33.16% above current price. The 52-week High is 8.61. It is 124.80% from the current price. The 52-week Low is 3.12. It is -18.54% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVUS is 1.42 on 2018-09-14. Short % to float is 4.75%. There are some statistics of NVUS. It is has market cap $36.05 million. The share outstanding is 9.42 million. The average volume is 239716. The percent of top 15 Institution holding is 70.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVUS is -38.42%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVUS is -34.66%.


Tags:

Share this post